Prof. Dr. Stephan Günther

Further involvements

• 26/09/2023

  • Poster
  • P-2-54

  Unraveling the viral genomic determinants of Ebola virus persistence

   Tropical and Emerging Infections
• 26/09/2023

  • Poster
  • P-2-86

  Reporter-virus-based screening for novel anti-Lassa virus drugs

   Tropical and Emerging Infections
• 26/09/2023

  • Poster
  • P-2-88

  The Antiviral Compound Testing Platform (ACTP) and its application to identify broad-spectrum antivirals

   Tropical and Emerging Infections
• 26/09/2023

  • Poster
  • P-2-95

  A novel SARS-CoV-2 replicon system expressing a secreted luciferase and the GFP-zeocin fusion protein

   Tropical and Emerging Infections
• 26/09/2023

  • Poster
  • P-2-100

  Clinical performance evaluation of a real-time PCR kit for the detection of Lassa virus

   Tropical and Emerging Infections
• 26/09/2023

  • Poster
  • P-2-102

  System serology in Lassa fever survivors from Edo State, Nigeria

   Tropical and Emerging Infections
• 26/09/2023

  • Poster
  • P-2-109

  Follow-up of survivors of Lassa Fever in Edo State, Nigeria: studies of correlates of immunity

   Tropical and Emerging Infections
• 26/09/2023

  15:40 – 15:50 8 Min. 2 Min.

  • Short Talk
  • S-6-5

  A randomized controlled phase II clinical trial assessing pharmacokinetics of favipiravir for the treatment of Lassa fever

   Tropical and Emerging Infections